168 related articles for article (PubMed ID: 31312595)
21. Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the
Venneker S; Kruisselbrink AB; Briaire-de Bruijn IH; de Jong Y; van Wijnen AJ; Danen EHJ; Bovée JVMG
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31810230
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes.
de Jong Y; Ingola M; Briaire-de Bruijn IH; Kruisselbrink AB; Venneker S; Palubeckaite I; Heijs BPAM; Cleton-Jansen AM; Haas RLM; Bovée JVMG
Clin Sarcoma Res; 2019; 9():9. PubMed ID: 31160965
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells.
Sunada S; Cartwright IM; Hirakawa H; Fujimori A; Uesaka M; Kato TA
Oncol Lett; 2017 Jun; 13(6):4911-4916. PubMed ID: 28599495
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermia-induced radiosensitization in CHO wild-type, NHEJ repair mutant and HR repair mutant following proton and carbon-ion exposure.
Maeda J; Fujii Y; Fujisawa H; Hirakawa H; Cartwright IM; Uesaka M; Kitamura H; Fujimori A; Kato TA
Oncol Lett; 2015 Nov; 10(5):2828-2834. PubMed ID: 26722249
[TBL] [Abstract][Full Text] [Related]
25. PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells.
Ghorai A; Sarma A; Chowdhury P; Ghosh U
Radiat Oncol; 2016 Sep; 11(1):126. PubMed ID: 27659937
[TBL] [Abstract][Full Text] [Related]
26. DNA double-strand breaks in cancer cells as a function of proton linear energy transfer and its variation in time.
Keta O; Petković V; Cirrone P; Petringa G; Cuttone G; Sakata D; Shin WG; Incerti S; Petrović I; Ristić Fira A
Int J Radiat Biol; 2021; 97(9):1229-1240. PubMed ID: 34187289
[TBL] [Abstract][Full Text] [Related]
27. An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.
Nile DL; Rae C; Hyndman IJ; Gaze MN; Mairs RJ
BMC Cancer; 2016 Aug; 16():621. PubMed ID: 27515310
[TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Zhou ZR; Zhu XD; Zhao W; Qu S; Su F; Huang ST; Ma JL; Li XY
Oncol Rep; 2013 Jun; 29(6):2498-506. PubMed ID: 23563481
[TBL] [Abstract][Full Text] [Related]
29. PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells.
Liu C; Gross N; Li Y; Li G; Wang Z; Zhong S; Li Y; Hu G
J Cell Mol Med; 2020 Feb; 24(4):2444-2450. PubMed ID: 31957270
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft.
Senra JM; Telfer BA; Cherry KE; McCrudden CM; Hirst DG; O'Connor MJ; Wedge SR; Stratford IJ
Mol Cancer Ther; 2011 Oct; 10(10):1949-58. PubMed ID: 21825006
[TBL] [Abstract][Full Text] [Related]
31. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723
[TBL] [Abstract][Full Text] [Related]
32. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation.
Waissi W; Nicol A; Jung M; Rousseau M; Jarnet D; Noel G; Burckel H
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33573176
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas.
Bi Y; Verginadis II; Dey S; Lin L; Guo L; Zheng Y; Koumenis C
Gynecol Oncol; 2018 Sep; 150(3):534-544. PubMed ID: 30025822
[TBL] [Abstract][Full Text] [Related]
36. PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports.
Collot T; Niogret J; Carnet M; Chevrier S; Humblin E; Favier L; Bengrine-Lefevre L; Desmoulins I; Arnould L; Boidot R
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236159
[TBL] [Abstract][Full Text] [Related]
37. Comparable Senescence Induction in Three-dimensional Human Cartilage Model by Exposure to Therapeutic Doses of X-rays or C-ions.
Hamdi DH; Chevalier F; Groetz JE; Durantel F; Thuret JY; Mann C; Saintigny Y
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):139-146. PubMed ID: 27084635
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
Philip CA; Laskov I; Beauchamp MC; Marques M; Amin O; Bitharas J; Kessous R; Kogan L; Baloch T; Gotlieb WH; Yasmeen A
BMC Cancer; 2017 Sep; 17(1):638. PubMed ID: 28886696
[TBL] [Abstract][Full Text] [Related]
39. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
40. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.
Uhl M; Mattke M; Welzel T; Oelmann J; Habl G; Jensen AD; Ellerbrock M; Haberer T; Herfarth KK; Debus J
Cancer; 2014 May; 120(10):1579-85. PubMed ID: 24500784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
